Norris Medicines

{
  "main_header": {
    "sid": 210607,
    "name": "Norris Medicines",
    "stock_name": "Norris Medicines",
    "full_name": "Norris Medicines Ltd",
    "name_url": "stocks-analysis/norris-medicines",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "18.24",
    "chg": 0.64,
    "chgp": "3.64%",
    "dir": 1,
    "prev_price": "17.60",
    "mcapval": "18.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524414,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 4,
    "sector_id": 79,
    "indexname": "India SENSEX",
    "isin": "INE744C01029",
    "curr_date": "Sep 18, 03:30 PM",
    "curr_time": "10:28 AM",
    "last_traded_at": "Sep 18, 03:30 PM IST",
    "bse_nse_vol": "5.34 k",
    "exc_status": "Active",
    "traded_date": "Sep 18, 2026",
    "traded_date_str": "2026 09 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/norris-medicines-210607-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Norris Medicines Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/norris-medicines-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-4188755",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NorrisMedicines_mojoScore_4188755.png",
        "date": "2026-09-10 08:26:29",
        "description": "Norris Medicines Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Strong Sell to Sell as of 9 September 2026. This change is primarily driven by a shift in technical indicators signalling a mildly bullish trend, despite persistent fundamental weaknesses and valuation concerns. The company’s stock price rose 5.00% on the day following the upgrade, reflecting renewed investor interest amid mixed signals."
      },
      {
        "title": "Norris Medicines Ltd Downgraded to Strong Sell Amidst Weak Fundamentals and Technical Setbacks",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/norris-medicines-ltd-downgraded-to-strong-sell-amidst-weak-fundamentals-and-technical-setbacks-4179032",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/NorrisMedicines_mojoScore_4179032.png",
        "date": "2026-09-02 08:49:36",
        "description": "Norris Medicines Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 September 2026. This shift reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid a challenging market environment."
      },
      {
        "title": "Norris Medicines Ltd Downgraded to Strong Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/norris-medicines-ltd-downgraded-to-strong-sell-amid-mixed-financial-and-technical-signals-4139398",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NorrisMedicines_mojoScore_4139398.png",
        "date": "2026-08-06 08:32:45",
        "description": "Norris Medicines Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 5 August 2026. This revision follows a comprehensive reassessment of the company’s quality, valuation, financial trends, and technical indicators, reflecting a cautious outlook despite some recent positive financial results."
      },
      {
        "title": "Norris Medicines Ltd Upgraded to 'Sell' as Technicals Improve Amid Lingering Fundamental Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/norris-medicines-ltd-upgraded-to-sell-as-technicals-improve-amid-lingering-fundamental-concerns-4133071",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NorrisMedicines_mojoScore_4133071.png",
        "date": "2026-08-03 08:13:15",
        "description": "Norris Medicines Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Strong Sell to Sell as of 31 July 2026. This change reflects a nuanced shift in the company’s technical outlook, even as fundamental concerns persist. The upgrade is primarily driven by improvements in technical indicators, while valuation and financial trends continue to weigh on investor sentiment."
      },
      {
        "title": "Golden Cross Forms in Norris Medicines Ltd — On a Day the Stock Fell 3.8%. What the Mixed Signals Mean",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4130569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NorrisMedicines_goldencross_4130569.png",
        "date": "2026-07-31 18:00:17",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Norris Medicines Ltd, signalling a golden cross on 31 Jul 2026. Yet, the stock declined 3.78% on the same day, while monthly momentum indicators remain bearish. This divergence between the moving averages and price action calls for a detailed examination of the signal's reliability."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Norris Medicines Ltd to 52-Week High of Rs 19.63",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-hits-new-52-week-high-at-rs1963-4093177",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NorrisMedicines_priceRelatedfactors_4093177.png",
        "date": "2026-07-08 09:41:59",
        "description": "With a decisive surge to Rs 19.63 on 8 Jul 2026, Norris Medicines Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical signals and sustained price momentum over the past week."
      }
    ],
    "total": 263,
    "sid": "210607",
    "stock_news_url": "https://www.marketsmojo.com/news/norris-medicines-210607"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Sep-2026",
      "details": "Newspaper advertisement regarding the 35th Annual General Meeting of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Book Closure For 35Th AGM Of The Company.",
      "datetime": "04-Sep-2026",
      "details": "Intimation of Book Closure for 35th AGM of the Company",
      "source": "BSE"
    },
    {
      "caption": "Notice Of 35Th Annual General Meeting Of The Company For The Financial Year 2025-26",
      "datetime": "04-Sep-2026",
      "details": "Notice of 35th Annual General Meeting of the Company for the Financial Year 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Norris Medicines Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-09-10 08:26:29

Norris Medicines Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Strong Sell to Sell as of 9 September 2026. This change is primarily driven by a shift in technical indicators signalling a mildly bullish trend, despite persistent fundamental weaknesses and valuation concerns. The company’s stock price rose 5.00% on the day following the upgrade, reflecting renewed investor interest amid mixed signals.

Read full news article

Norris Medicines Ltd Downgraded to Strong Sell Amidst Weak Fundamentals and Technical Setbacks

2026-09-02 08:49:36

Norris Medicines Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 September 2026. This shift reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid a challenging market environment.

Read full news article

Norris Medicines Ltd Downgraded to Strong Sell Amid Mixed Financial and Technical Signals

2026-08-06 08:32:45

Norris Medicines Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 5 August 2026. This revision follows a comprehensive reassessment of the company’s quality, valuation, financial trends, and technical indicators, reflecting a cautious outlook despite some recent positive financial results.

Read full news article

Norris Medicines Ltd Upgraded to 'Sell' as Technicals Improve Amid Lingering Fundamental Concerns

2026-08-03 08:13:15

Norris Medicines Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Strong Sell to Sell as of 31 July 2026. This change reflects a nuanced shift in the company’s technical outlook, even as fundamental concerns persist. The upgrade is primarily driven by improvements in technical indicators, while valuation and financial trends continue to weigh on investor sentiment.

Read full news article

Golden Cross Forms in Norris Medicines Ltd — On a Day the Stock Fell 3.8%. What the Mixed Signals Mean

2026-07-31 18:00:17

The 50-day moving average has crossed above the 200-day moving average for Norris Medicines Ltd, signalling a golden cross on 31 Jul 2026. Yet, the stock declined 3.78% on the same day, while monthly momentum indicators remain bearish. This divergence between the moving averages and price action calls for a detailed examination of the signal's reliability.

Read full news article

Broad-Based Technical Strength Lifts Norris Medicines Ltd to 52-Week High of Rs 19.63

2026-07-08 09:41:59

With a decisive surge to Rs 19.63 on 8 Jul 2026, Norris Medicines Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical signals and sustained price momentum over the past week.

Read full news article

View All News